A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR THE PREVENTION OF ACUTE KIDNEY INJURY IN SUBJECTS AT HIGH RISK FOR AKI FOLLOWING CARDIAC SURGERY
- Registry ID
- QRK209
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- QUARK PHARMACEUTICALS INC
- Start date
- 2017-04-07
- Last update
- 2016-03-10
Conditions
- KIDNEY DISEASE
- CARDIAC SURGERY
Related clinical trials
- PODOMOUNT-BASKET, A PHASE II, MULTICENTRE, RANDOMISED, 2-ARM PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED BASKET TRIAL TO ASSESS SAFETY, TOLERABILITY, PK, AND EFFICACY OF BI 764198 IN FOUR PROTEINURIC KIDNEY DISEASES
- A PHASE 2A, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VX-407 IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WHO HAVE A SUBSET OF PKD1 GENE VARIANTS
- AUTO-PLTS: THE EFFECTIVENESS OF AUTOLOGOUS, COLD-STORED PLATELETS
COLLECTED 7-10 DAYS BEFORE CARDI-AC SURGERY FOR AVOIDANCE OF
ALLOGENEIC TRANSFUSIONS: A RANDOMIZED PATIENT PREFERENCE TRIAL
- BLEEDING REDUCTION IN ACUTE AND CHRONIC KIDNEY PATIENTS HAVING SURGERY
(BRACKETS) PILOT TRIAL
- A PHASE 2B, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL GROUP
DOSE-FINDING CLINICAL STUDY TO EVALUATE THE EFFICACY ON RENAL FUNCTION, AND
SAFETY, OF RMC-035 IN PARTICIPANTS AT HIGH RISK FOR KIDNEY INJURY FOLLOWING
OPEN-CHEST CARDIAC SURGERY
- A RANDOMIZED, MULTI-CENTRIC, PLACEBO-CONTROLLED, PARTICIPANT AND INVESTIGATOR-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF TIN816 IN ADULT PATIENTS AT RISK FOR ACUTE KIDNEY INJURY FOLLOWING CARDIAC SURGERY
View on source registry